Betazak-16 Betahistine Dihydrochloride 16 mg Tablet 10 PIECES

IMPORTANT NOTICE (Rx): This product is classified as a Prescription-Only Medicine (Rx) in the Philippines. It is a targeted antivertigo inner ear microcirculation therapy that must strictly be purchased and taken under the direct clinical diagnosis, monitoring, and prescription of a licensed physician. Complete the full course of therapy as directed by your doctor.

Betazak-16 Betahistine Dihydrochloride 16 mg Tablet (Targeted Inner Ear Microcirculation & Vertigo Maintenance Therapy Sold by blister pack of 10 pieces) is an essential oral formulation prescribed for the management, symptom reduction, and relief of vestibular vertigo, balance disturbances, and Ménière’s syndrome.

• Packaging & Quantity: Sold by blister pack of 10 pieces (1 sealed foil blister strip containing 10 tablets). Each tablet delivers 16 mg of active Betahistine (as dihydrochloride).

• Inner Ear Microvascular Vasodilation: Acts as a selective histamine H3 receptor antagonist and weak H1 receptor agonist to improve localized blood flow and microcirculation in the labyrinth and stria vascularis of the inner ear, reducing endolymphatic fluid pressure.

Targeted Clinical Indications:

• Management of vestibular vertigo, balance instability, and true spinning sensations.

• Reduction of ringing, buzzing, or humming sensations in the ears (tinnitus).

• Relief of inner ear fullness, pressure feelings, and associated nausea or dizzy spells caused by inner ear disorders.

Directions for Use: Swallow the tablet with a full glass of water, preferably with or after meals to minimize mild digestive discomfort:

• Standard Adult Maintenance Dose: 16 mg (1 tablet) 3 times daily (totaling 48 mg per day), or strictly as evaluated and prescribed by your physician.

• Consistent daily use is essential, as clinical improvements may develop progressively over several weeks of treatment.

• Safety Precautions & Warnings: Contraindicated in patients with pheochromocytoma (a rare tumor of the adrenal gland). Use with caution in patients with a history of bronchial asthma or peptic ulcer disease. Concurrent use with strong antihistamines may reduce the therapeutic benefits of betahistine. Discontinue use and consult your doctor if mild skin rashes, persistent headache, or stomach discomfort occurs.

• Storage Guidance: Store at temperatures not exceeding 30°C in a dry place protected from excessive heat, moisture, and direct sunlight. Keep the blister pack intact until use and securely out of reach of children.

FDA Registration No.: DRP-15750